To determine if the Ctr9 signature has a broader clinical significance, we mined breast cancer outcome-linked gene expression data using the Gene Expression-Based Outcome for Breast Cancer Online (GOBO) tool [37]. This evidence concerns the gene CTR9 and breast cancer.